Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00859066 · ClinicalTrials.gov registry record
Evaluation of Radiology Resident Anxiety When Beginning Emergency Room (ER) Call
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 19
- Enrollment target
NCT00859066: Clinical Trial study, sponsored by University of Michigan.
NCT00859066 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00859066 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to quantify levels of resident anxiety under the current system (take call alone) and compare results to a modified system.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-12 |
Why NCT00859066 stopped before completion
NCT00859066 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00859066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00859066 about?
NCT00859066 is a clinical study titled "Evaluation of Radiology Resident Anxiety When Beginning Emergency Room (ER) Call". The purpose of this study is to quantify levels of resident anxiety under the current system (take call alone) and compare results to a modified system.
What is the current status of trial NCT00859066?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2009-01. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00859066?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia